BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials...

Optimi Health Corp. Receives Receipt For Final Prospectus and Conditional Approval to List on the CSE NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...

Neo Performance Materials Inc. Files Final Prospectus and Announces Pricing of Initial Public Offering NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. (the "Company") announced today...